Dr. Ryan Bakke

Dr. Ryan Bakke (DR. RYAN BAKKE ) is A Dentist Physician in Yankton, SD. The NPI Number for Dr. Ryan Bakke is 1669464095.

The current location address for Dr. Ryan Bakke is 232 CAPITOL ST Yankton, SD 57078 and the contact number is and fax number is . The mailing address for Dr. Ryan Bakke is 519 MAPLE ST Yankton, SD 57078- 6056657476 (mailing address contact number - ).

A dentist is a person qualified by a doctorate in dental surgery (D.D.S.) or dental medicine (D.M.D.), licensed by the state to practice dentistry, and practicing within the scope of that license. There is no difference between the two degrees: dentists who have a DMD or DDS have the same education. Universities have the prerogative to determine what degree is awarded. Both degrees use the same curriculum requirements set by the American Dental Association's Commission on Dental Accreditation. Generally, three or more years of undergraduate education plus four years of dental school is required to graduate and become a general dentist. State licensing boards accept either degree as equivalent, and both degrees allow licensed individuals to practice the same scope of general dentistry. Additional post-graduate training is required to become a dental specialist.

What is the NPI Number for Dr. Ryan Bakke ?

Answer: The NPI Number for Dr. Ryan Bakke is 1669464095

Where is Dr. Ryan Bakke located?

Answer: Dr. Ryan Bakke is located at 232 CAPITOL ST Yankton, SD 57078.

What is the specialty for Dr. Ryan Bakke ?

Answer: The Specialty of Dr. Ryan Bakke is A Dentist Physician.

Are there any online reviews for Dr. Ryan Bakke ?

Answer: Not yet!

Are there any other health care providers in Yankton, SD?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dentist
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	86
Number of Standardized 30-Day Fills	86
Aggregate Cost Paid for All Claims	391.23
Number of Day's Supply for All Claims	575
Number of Medicare Beneficiaries	58
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	#
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	85
Aggregate Cost Paid for Generic Drugs	383.86
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	*
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	11
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	58.9
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	75
Aggregate Cost Paid for Claims Filled by	332.33
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	17
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	110.84
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	69
by Low-Income Subsidy	280.39
Total Claims of Opioid Drugs, Including
Aggregate Cost Paid for Opioid Drugs
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms
Total Claims of Long-Acting Opioid Drugs
Aggregate Cost Paid for Long-Acting Opioid
Number of Day's Supply of All Long-Acting
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	65
Aggregate Cost Paid for Antibiotic Drugs	207.21
Antibiotic Claims	54
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	73.620689655
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	29
Number of Male Beneficiaries	29
Number of Non-Hispanic White	56
Number of Black or African American	0
Number of Asian Pacific Islander	0
Number of Hispanic Beneficiaries	0
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.2459743874